doxapram has been researched along with Body Weight in 5 studies
Doxapram: A central respiratory stimulant with a brief duration of action. (From Martindale, The Extra Pharmocopoeia, 30th ed, p1225)
doxapram : A member of the class of pyrrolidin-2-ones that is N-ethylpyrrolidin-2-one in which both of the hydrogens at the 3 position (adjacent to the carbonyl group) are substituted by phenyl groups, and one of the hydrogens at the 4 position is substituted by a 2-(morpholin-4-yl)ethyl group. A central and respiratory stimulant with a brief duration of action, it is used (generally as the hydrochloride or the hydrochloride hydrate) as a temporary treatment of acute respiratory failure, particularly when superimposed on chronic obstructive pulmonary disease, and of postoperative respiratory depression. It has also been used for treatment of postoperative shivering.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "5 mg/kg/h theophylline) were administered in that order and in reverse order to patients with apnea of prematurity." | 7.68 | Lack of a pharmacokinetic interaction between doxapram and theophylline in apnea of prematurity. ( Coutts, RT; Finer, NN; Jamali, F; Malek, F; Peliowski, A, 1991) |
| "5 mg/kg/h theophylline) were administered in that order and in reverse order to patients with apnea of prematurity." | 3.68 | Lack of a pharmacokinetic interaction between doxapram and theophylline in apnea of prematurity. ( Coutts, RT; Finer, NN; Jamali, F; Malek, F; Peliowski, A, 1991) |
| "The sleep apnea syndromes have been recognized clinically in the United States only within the past ten years." | 2.36 | Sleep apnea syndromes. ( Chaudhary, BA; Speir, WA, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaudhary, BA | 1 |
| Speir, WA | 1 |
| Jamali, F | 1 |
| Coutts, RT | 1 |
| Malek, F | 1 |
| Finer, NN | 1 |
| Peliowski, A | 1 |
| Pavan, WL | 1 |
| Gupta, PK | 2 |
| Dundee, JW | 2 |
1 review available for doxapram and Body Weight
| Article | Year |
|---|---|
Sleep apnea syndromes.
Topics: Body Weight; Doxapram; Humans; Oxygen Inhalation Therapy; Physical Examination; Progesterone; Sleep | 1982 |
1 trial available for doxapram and Body Weight
| Article | Year |
|---|---|
Morphine combined with doxapram or naloxone. A study of post-operative pain relief.
Topics: Adolescent; Adult; Aged; Analgesia; Blood Pressure; Body Weight; Clinical Trials as Topic; Doxapram; | 1974 |
3 other studies available for doxapram and Body Weight
| Article | Year |
|---|---|
Lack of a pharmacokinetic interaction between doxapram and theophylline in apnea of prematurity.
Topics: Apnea; Body Weight; Doxapram; Drug Interactions; Female; Gestational Age; Half-Life; Humans; Infant, | 1991 |
[Doxapram: clinical experience with a new respiratory stimulant].
Topics: Adolescent; Adult; Aged; Body Weight; Central Nervous System Stimulants; Child; Doxapram; Humans; Mi | 1968 |
Alterations in response to somatic pain associated with anaesthesia. XXII. Nikethamide, doxapram and naloxone.
Topics: Anesthesia; Body Weight; Doxapram; Female; Humans; Meperidine; Morphine; Naloxone; Nikethamide; Pain | 1973 |